Trials / Sponsors / National Center for Tumor Diseases, Heidelberg

National Center for Tumor Diseases, Heidelberg

Academic / Other · 12 registered clinical trials.

Status	Trial	Phase	Started
Completed	Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors Cancers With DNA Repair-Deficiency	Phase 2	2018-10-25
Terminated	Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Canc Colorectal Carcinoma	Phase 1	2016-05-01
Completed	Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas Glioma	Phase 1	2015-06-01
Completed	CCR5-blockade in Metastatic Colorectal Cancer Colorectal Cancer, Neoplasm Metastasis, Liver Metastases	—	2012-11-01
Completed	Vorinostat in Children Children With Relapsed Solid Tumor, Lymphoma or Leukemia	Phase 1 / Phase 2	2012-03-01
Completed	Neoadjuvant Radiochemotherapy Combined With Panitumumab in Locally Advanced KRAS Wild-type Rectal Cancer Rectal Cancer	Phase 2	2011-07-01
Unknown	Effects of ECA on Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades Pain	N/A	2011-05-01
Completed	Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1 Metastatic Melanoma	Phase 2	2010-11-01
Terminated	Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinom Adenocarcinomas of the Esophagogastric Junction	Phase 2	2010-10-01
Terminated	Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal Cancer GastroEsophageal Cancer	Phase 2	2010-06-01
Terminated	Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer Pancreatic Cancer	Phase 3	2010-03-01
Terminated	Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC Colorectal Carcinoma	Phase 2	2009-06-01